One such isolate, compound 121 inhibited breast cancer cell growth via down-regulation of the NF-κB and up-regulation of the Heme oxygenase-1 (HO-1) pathways in a dose-responsive manner, with an IC50 value of 1.6 μM [152]. Here, HMOX1 is linked to breast carcinoma.